News

Bangalore's VNIR Biotech launches molecular COVID-19 test probes

These molecular probes are used to track the amplification in PCR. Their immediate application is for COVID-19 testing.

Jul 13, 2020

By : Team ABLE

Russia announces completion of world’s first COVID-19 vaccine human trials

Russia had allowed clinical trials of two forms of a potential Covid-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology.

Jul 13, 2020

By : Team ABLE

Numab, Boehringer Ingelheim collaborate to develop multi-specific antibody therapeutics for cancer

The T-cell engager to be developed with Numab adds to Boehringer Ingelheim’s growing cancer immunology portfolio.

Jul 09, 2020

By : Team ABLE

European Investment Bank and CureVac sign €75 million loan agreement for development of vaccine candidate against SARS-CoV-2

CureVac’s mRNA technology platform has believed to have shown potential in the clinical development and production of mRNA based vaccines and therapeutics.

Jul 09, 2020

By : Team ABLE

The European Molecular Biology Organisation extends lifetime membership to NCBS scientist Sumantra Chattarji

It is believed that EMBO bestows lifetime membership to only a few selected scientists across the world who have done outstanding work in their respective fields.

Jul 09, 2020

By : Team ABLE